Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 62.50
High: 0.00
Low: 0.00
Prev. Close: 62.50
JAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

5 May 2021 10:24

RNS Number : 6260X
Mandarin Oriental International Ltd
05 May 2021
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

5th May 2021 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2021.

 

Trading conditions in the first quarter were extremely challenging due to the continuing impact of COVID-19 and ongoing actions by governments to control it.

 

In Asia, border restrictions greatly limited demand, except in the Chinese mainland where occupancy was supported by strong local consumption in a large domestic market. In Europe, conditions worsened as the quarter progressed. The operating environment in America has improved slowly. By the middle of April, all of the Group's hotels were operational.

 

On the 15th April 2021, the Group reopened the restored Mandarin Oriental Ritz, Madrid, which will be a flagship property in the portfolio.

 

Unaudited underlying losses were US$41 million in the first quarter and a further loss is expected in the second quarter. As noted when the Group's 2020 results were announced in March, the outlook for the second half of the year is uncertain. A successful roll-out of COVID-19 vaccination programmes across the Group's markets, together with the relaxation of current travel restrictions, will be crucial for the restoration of viable operating conditions.

 

The Group's financial position remains robust. Net debt at 31st March 2021 was US$536 million and the Group held US$150 million of cash reserves and US$403 million in available, committed debt facilities. Gearing was 10% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

 

Brunswick Group Limited

Sunitha Chalam (852) 3512 5050

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKELBBFELLBBF
Date   Source Headline
10th May 202411:49 amRNSTransaction in Own Shares
9th May 202411:41 amRNSTransaction in Own Shares
9th May 202411:19 amRNSAdditional Listing
8th May 20241:15 pmRNSResult of AGM
8th May 202411:28 amRNSTransaction in Own Shares
7th May 202412:27 pmRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 202411:52 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 202410:32 amRNSDividend
30th Apr 202411:27 amRNSTotal Voting Rights
30th Apr 202411:20 amRNSTransaction in Own Shares
30th Apr 202410:23 amRNSPT HERO SUPERMARKET TBK THREE MONTHS 2024 RESULTS
29th Apr 202412:19 pmRNSTransaction in Own Shares
29th Apr 202411:58 amRNSJC&C Interim Management Statement
29th Apr 202411:54 amRNSPT Astra 2024 First Quarter Financial Statements
26th Apr 202411:51 amRNSTransaction in Own Shares
26th Apr 202411:34 amRNSDividend
25th Apr 202411:51 amRNSTransaction in Own Shares
24th Apr 202411:56 amRNSTransaction in Own Shares
23rd Apr 202411:47 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 202412:44 pmRNSTransaction in Own Shares
18th Apr 202412:34 pmRNSTransaction in Own Shares
17th Apr 202411:29 amRNSTransaction in Own Shares
16th Apr 20241:23 pmRNSTransaction in Own Shares
15th Apr 202411:47 amRNSTransaction in Own Shares
12th Apr 202411:07 amRNSTransaction in Own Shares
9th Apr 202411:17 amRNSTransaction in Own Shares
9th Apr 202410:22 amRNSAnnual Financial Report
5th Apr 202411:59 amRNSTransaction in Own Shares
3rd Apr 20243:48 pmRNSTransaction in Own Shares
3rd Apr 202410:33 amRNSCirc re. Scrip Dividend Scheme
2nd Apr 202411:53 amRNSTransaction in Own Shares
28th Mar 202411:04 amRNSTotal Voting Rights
28th Mar 202410:56 amRNSTransaction in Own Shares
27th Mar 202410:11 amRNSTransaction in Own Shares
26th Mar 20241:24 pmRNSTransaction in Own Shares
25th Mar 20242:13 pmRNSTransaction in Own Shares
25th Mar 202410:23 amRNSBlock listing Interim Review
22nd Mar 202411:34 amRNSTransaction in Own Shares
21st Mar 202411:06 amRNSTransaction in Own Shares
19th Mar 20249:49 amRNSDirector/PDMR Shareholding
13th Mar 202411:21 amRNSTransaction in Own Shares
13th Mar 20248:59 amRNSPT HERO SUPERMARKET TBK FULL YEAR 2023 RESULTS
12th Mar 202410:08 amRNSDirector/PDMR Shareholding
12th Mar 20249:57 amRNSCorrection: Director/PDMR Shareholding
11th Mar 202410:15 amRNSTransaction in Own Shares
7th Mar 202412:21 pmRNS2023 Preliminary Results
7th Mar 202412:02 pmRNS2023 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.